Sunitinib Malate in Treating Patients With Kidney Cancer
NCT00943839
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Kidney Cancer
Interventions
DRUG:
sunitinib malate
OTHER:
laboratory biomarker analysis
OTHER:
pharmacological study
Sponsor
Centre Antoine Lacassagne